Document Detail

Metabolic Syndrome and Heart Failure-The Risk, Paradox, and Treatment.
MedLine Citation:
PMID:  21298579     Owner:  NLM     Status:  Publisher    
The constellation of obesity, hypertension, dyslipidemia, and insulin resistance-together referred to as metabolic syndrome (MetS)-is increasing in prevalence in the American population and also worldwide. The individual components of MetS and MetS as a whole increase the risk of heart failure, cardiovascular mortality, and all-cause mortality. Despite this adverse association, numerous studies have documented an obesity paradox, in which overweight and obese people with established cardiovascular disease, including hypertension, coronary heart disease, heart failure, and peripheral arterial disease, have a better prognosis than patients who are not overweight or obese. Current treatment strategies for these patients include weight loss, control of blood pressure and cholesterol levels, and treatment of hyperglycemia. Because of increasing evidence for the obesity paradox, some physicians question whether obesity should be treated when it is associated with heart failure. Several studies have shown improvement in left ventricular function and decreased mortality and morbidity from heart failure with weight loss and treatment of elevated blood pressure, cholesterol, and hyperglycemia. The most reasonable approach at this time appears to be weight loss and exercise, lowering blood pressure to less than 130/80 mm Hg, low-density lipoprotein (LDL) cholesterol to less than 100 mg/dL, and glycosylated hemoglobin levels to less than 7%.
Krishna K Gaddam; Hector O Ventura; Carl J Lavie
Related Documents :
1507079 - Effect of insole material on force and plantar pressures during walking.
23781269 - Hypothalamus-related resting brain network underlying short-term acupuncture treatment ...
14751109 - The effect of the wafer procedure on pressure in the distal radioulnar joint.
23614849 - Physician-pharmacist co-management and 24-hour blood pressure control.
10998609 - Comparison of an in-shoe pressure measurement device to a force plate: concurrent valid...
17118499 - Dynamic measurement of patellofemoral contact pressure following reconstruction of the ...
11527139 - Primary prevention with beta-blockade in patients with hypertension: review of results ...
24059619 - Phase contrast mr as non-invasive tool in the diagnosis of benign intracranial hyperten...
1694749 - Cerebral electrophysiologic effects of resuscitation with hypertonic saline-dextran aft...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-8
Journal Detail:
Title:  Current hypertension reports     Volume:  -     ISSN:  1534-3111     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888982     Medline TA:  Curr Hypertens Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute Ochsner Clinical School - The University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA, 70121, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vitamin D Therapy and Cardiovascular Health.
Next Document:  Compartmentation of the Cerebellar Cortex in the Naked Mole-Rat (Heterocephalus glaber).